Refining Incidence and Characteristics of Inflammatory Myopathies: A Quadruple‐Source Capture–Recapture Survey Using the 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria

Author:

Debrut Léa1ORCID,Giannini Margherita2ORCID,Klein Delphine3,Spielmann Lionel4,Mertz Philippe5ORCID,Martin Thierry6,Nadaj‐Pakleza Aleksandra7,Hirschi Sandrine8,Nespola Benoit9,Lannes Béatrice10,Terzic Joëlle11,Hinschberger Olivier12,Dervieux Benjamin13,Lipsker Dan14,Arnaud Laurent5ORCID,Gottenberg Jacques‐Eric5ORCID,Kleinmann Jean François5,Geny Bernard2,Séverac François15,Velten Michel3,Sibilia Jean5,Meyer Alain16ORCID

Affiliation:

1. UR3072 Centre de Recherche en Biomédecine, Université de Strasbourg Strasbourg France

2. UR3072 Centre de Recherche en Biomédecine, Université de Strasbourg, and Explorations fonctionnelles musculaires, Service de physiologie, Hôpitaux Universitaires de Strasbourg Strasbourg France

3. INSERM UMR‐S1113, Registre des cancers du Bas‐Rhin, Fédération de Médecine Translationnelle, Université de Strasbourg Strasbourg France

4. Service de rhumatologie Centre Hospitalier de Colmar Colmar France

5. Service de rhumatologie, Centre de Référence des Maladies Autoimmunes Rares (RESO), Hôpitaux Universitaire de Strasbourg Strasbourg France

6. Service de médecine interne, RESO, Hôpitaux Universitaire de Strasbourg Strasbourg France

7. Service de neurologie, Centre de Référence des Maladies Neuro‐musculaires, Hôpitaux Universitaire de Strasbourg Strasbourg France

8. Service de pneumologie, Centre de Compétence des Maladies Pulmonaires Rares, Hôpitaux Universitaire de Strasbourg Strasbourg France

9. Laboratoire d'immunologie Hôpitaux Universitaires de Strasbourg Strasbourg France

10. Département de pathologie Hôpitaux Universitaires de Strasbourg Strasbourg France

11. Service de pédiatrie, Centre de compétence des rhumatismes inflammatoires et maladies auto‐immunes systémiques rares de l'enfant (RAISE) Hôpitaux Universitaires de Strasbourg Strasbourg France

12. Service de médecine interne, Centre de Compétence des Maladies Auto‐immunes Rares Centre Hospitalier de Colmar Colmar France

13. Service de médecine interne, Centre de Compétence des Maladies Auto‐immunes Rares Centre Hospitalier de Mulhouse Mulhouse France

14. Service de dermatologie Hôpitaux Universitaires de Strasbourg Strasbourg France

15. Pôle de Santé Publique, Secteur Méthodologie et Biostatistiques Hôpitaux Universitaires de Strasbourg Strasbourg France

16. UR3072 Centre de Recherche en Biomédecine, Université de Strasbourg, Explorations fonctionnelles musculaires, Service de physiologie, Hôpitaux Universitaires de Strasbourg, and Service de rhumatologie, RESO, Hôpitaux Universitaire de Strasbourg Strasbourg France

Abstract

ObjectiveInflammatory myopathies (IM), characterized by muscle inflammation and weakness, are rare systemic diseases. Our previous study estimated an IM incidence rate of 7.98 cases per million people per year (95% confidence interval 7.38–8.66) and highlighted important variations that were likely because of methodologic issues rather than true epidemiologic differences. In this study, we aimed to refine the incidence of IM, using the 2017 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) classification criteria for IM and a quadruple‐source capture–recapture method during a 6‐year period in Alsace, France, a region with a population of 2 million having benefits of good access to health care and accredited IM referral centers.MethodsClinical data of potential IM patients were obtained from 4 sources (general practitioners and community specialists, public and private hospital records, public and private laboratories, and archives from the pathology department). Patients residing in Alsace and who fulfilled the 2017 EULAR/ACR criteria for IM between January 1, 2006, and January 1, 2013, were included. We corrected potentially incomplete ascertainment of cases with capture–recapture analyses. We studied both spatial and temporal distributions of incidence of IM. We also assessed systemic manifestations of the disease.ResultsOur review of 1,742 potential cases identified 106 patients with IM. No spatial or temporal heterogeneity was observed. Use of log‐linear models showed an estimated 14.9 additional missed cases. Thus, the incidence rate of IM was 8.22 new cases per million inhabitants per year (95% confidence interval 6.76–9.69). Extramuscular manifestations other than dermatomyositis rash were frequently recorded.ConclusionThe stringent methodology used in our study provides an accurate estimation of the incidence of IM. This study also demonstrates, in a population‐based cohort, the systemic nature of IM.image

Funder

Ministère des Affaires Sociales et de la Santé

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3